Gut microbiome profiling in systemic sclerosis: a metagenomic approach
Objectives: The early gastrointestinal (GI) manifestation of systemic sclerosis (SSc) suggests a possible GI microbiota engagement in the pathophysiology and/or progression of SSc. Previous studies have revealed dysbiosis among Caucasian SSc patients. This study extends these findings to Asian SSc p...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Published: |
Clinical and Experimental Rheumatology
2023
|
Subjects: | |
Online Access: | http://eprints.sunway.edu.my/2832/ https://doi.org/10.55563/clinexprheumatol/jof7nx |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.sunway.eprints.2832 |
---|---|
record_format |
eprints |
spelling |
my.sunway.eprints.28322024-07-22T07:38:54Z http://eprints.sunway.edu.my/2832/ Gut microbiome profiling in systemic sclerosis: a metagenomic approach Tan, Tze Chin Chandrasekaran, Lakshmi Leung, Ying Ying Purbojati, Rikky Pettersson, Sven * Low, Andrea Hsiu Ling QL Zoology RC Internal medicine RM Therapeutics. Pharmacology Objectives: The early gastrointestinal (GI) manifestation of systemic sclerosis (SSc) suggests a possible GI microbiota engagement in the pathophysiology and/or progression of SSc. Previous studies have revealed dysbiosis among Caucasian SSc patients. This study extends these findings to Asian SSc patients. Methods: Adult SSc patients, stratified according to 1) on immunosuppressive (On-IS) drugs or 2) no immunosuppressive drugs (No-IS), and age-and-sex-matched healthy controls (HC) were recruited. Metagenomic sequencing of stool DNA was compared between SSc patients and HC, and between SSc (On-IS) and (No-IS) patients. Alpha and beta-diversity, taxonomic and functional profiling were evaluated. Results: Twenty-three female SSc patients (12 On-IS; 11 No-IS; 5 diffuse and 18 limited SSc subtype) and 19 female HC, with median age of 54 years and 56 years, respectively, were recruited. Median SSc disease duration was 3.3 years. Alpha diversity was significantly higher in SSc versus HC (p=0.014) and in SSc (No-IS) versus HC (p=0.006). There was no significant difference in beta diversity between SSc and HC (p=0.307). At the phyla level, there were significantly increased abundance of Firmicutes and Actinobacteria in SSc versus HC, and reduced abundance of Bacteroidetes (all p<0.001). At the species level, there were significantly increased abundance of several Lactobacillus, Bifidobacterium, and Coprococcus species in SSc, and increased abundance of Odoribacter, Bacteroides and Prevotella species in HC. KEGG pathway analysis demonstrated distinct differences between SSc versus HC, and between SSc (No-IS) and SSc (On-IS). Conclusions: Using metagenomic sequencing, our study further underlines distinct alterations in microbiota profiling among Asian SSc patients. Clinical and Experimental Rheumatology 2023 Article PeerReviewed Tan, Tze Chin and Chandrasekaran, Lakshmi and Leung, Ying Ying and Purbojati, Rikky and Pettersson, Sven * and Low, Andrea Hsiu Ling (2023) Gut microbiome profiling in systemic sclerosis: a metagenomic approach. Clinical and Experimental Rheumatology, 41 (8). ISSN 0392-856x https://doi.org/10.55563/clinexprheumatol/jof7nx 10.55563/clinexprheumatol/jof7nx |
institution |
Sunway University |
building |
Sunway Campus Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
Sunway University |
content_source |
Sunway Institutional Repository |
url_provider |
http://eprints.sunway.edu.my/ |
topic |
QL Zoology RC Internal medicine RM Therapeutics. Pharmacology |
spellingShingle |
QL Zoology RC Internal medicine RM Therapeutics. Pharmacology Tan, Tze Chin Chandrasekaran, Lakshmi Leung, Ying Ying Purbojati, Rikky Pettersson, Sven * Low, Andrea Hsiu Ling Gut microbiome profiling in systemic sclerosis: a metagenomic approach |
description |
Objectives: The early gastrointestinal (GI) manifestation of systemic sclerosis (SSc) suggests a possible GI microbiota engagement in the pathophysiology and/or progression of SSc. Previous studies have revealed dysbiosis among Caucasian SSc patients. This study extends these findings to Asian SSc patients.
Methods: Adult SSc patients, stratified according to 1) on immunosuppressive (On-IS) drugs or 2) no immunosuppressive drugs (No-IS), and age-and-sex-matched healthy controls (HC) were recruited. Metagenomic sequencing of stool DNA was compared between SSc patients and HC, and between SSc (On-IS) and (No-IS) patients. Alpha and beta-diversity, taxonomic and functional profiling were evaluated.
Results: Twenty-three female SSc patients (12 On-IS; 11 No-IS; 5 diffuse and 18 limited SSc subtype) and 19 female HC, with median age of 54 years and 56 years, respectively, were recruited. Median SSc disease duration was 3.3 years. Alpha diversity was significantly higher in SSc versus HC (p=0.014) and in SSc (No-IS) versus HC (p=0.006). There was no significant difference in beta diversity between SSc and HC (p=0.307). At the phyla level, there were significantly increased abundance of Firmicutes and Actinobacteria in SSc versus HC, and reduced abundance of Bacteroidetes (all p<0.001). At the species level, there were significantly increased abundance of several Lactobacillus, Bifidobacterium, and Coprococcus species in SSc, and increased abundance of Odoribacter, Bacteroides and Prevotella species in HC. KEGG pathway analysis demonstrated distinct differences between SSc versus HC, and between SSc (No-IS) and SSc (On-IS).
Conclusions: Using metagenomic sequencing, our study further underlines distinct alterations in microbiota profiling among Asian SSc patients. |
format |
Article |
author |
Tan, Tze Chin Chandrasekaran, Lakshmi Leung, Ying Ying Purbojati, Rikky Pettersson, Sven * Low, Andrea Hsiu Ling |
author_facet |
Tan, Tze Chin Chandrasekaran, Lakshmi Leung, Ying Ying Purbojati, Rikky Pettersson, Sven * Low, Andrea Hsiu Ling |
author_sort |
Tan, Tze Chin |
title |
Gut microbiome profiling in systemic sclerosis: a metagenomic approach |
title_short |
Gut microbiome profiling in systemic sclerosis: a metagenomic approach |
title_full |
Gut microbiome profiling in systemic sclerosis: a metagenomic approach |
title_fullStr |
Gut microbiome profiling in systemic sclerosis: a metagenomic approach |
title_full_unstemmed |
Gut microbiome profiling in systemic sclerosis: a metagenomic approach |
title_sort |
gut microbiome profiling in systemic sclerosis: a metagenomic approach |
publisher |
Clinical and Experimental Rheumatology |
publishDate |
2023 |
url |
http://eprints.sunway.edu.my/2832/ https://doi.org/10.55563/clinexprheumatol/jof7nx |
_version_ |
1805893820013871104 |
score |
13.211869 |